Michael Becker compensation by year
RELMADA THERAPEUTICS Summary Compensation Table · the one fiscal year held| Component | FY2017 |
|---|---|
| Salary | $186,578 |
| Total | $186,578 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: RELMADA THERAPEUTICS, INC. DEF 14A filed January 9, 2019, accession 0001213900-19-000461, and prior-year filings. Open the filing on EDGAR.
How this page was built: the RELMADA THERAPEUTICS, INC. filed document, accession 0001213900-19-000461. Every figure is read from that document and cited to the page and table it appears in. Filed January 9, 2019.
RELMADA THERAPEUTICS’s named executive officers, FY2017
as the company reported each| Named executive officer | Role | FY2017 total |
|---|---|---|
| Richard Mangano | Former Chief Scientific Officer | $343,186 |
| Michael Becker · this page | Former Chief Financial Officer | $186,578 |
The full RELMADA THERAPEUTICS compensation record
free company briefThis page is one person within RELMADA THERAPEUTICS's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the RELMADA THERAPEUTICS proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are RELMADA THERAPEUTICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.